Condition: Benign Breast Lesions · Malignant Breast Tumours · Sponsor: Franciscus Gasthuis & Vlietland (Hospital)
The aim of this study is to evaluate the negative predictive value of the Photo Acoustic Imager 3+ (PAM3+) in the detection of female breast lesions (malignant and benign)in an outpatient setting.
This description comes directly from the study's public registry record.
Linda Riks, MD · 010 - 893 6010 · l.riks@franciscus.nl
Always discuss trial participation with your own doctor first.
| Franciscus Vlietland Ziekenhuis | Schiedam, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07492589